Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome

por Vermeulen, Sim, Awada, Gil, Keyaerts, Marleen, Neyns, Bart, Everaert, Hendrik
Publicado 2021

A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRAS(Q61R/K/L) Mutant Melanoma (TraMel-WT)

por Awada, Gil, Schwarze, Julia Katharina, Tijtgat, Jens, Fasolino, Giuseppe, Everaert, Hendrik, Neyns, Bart
Publicado 2021

Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report

por Lambert, Ine, Fasolino, Giuseppe, Awada, Gil, Kuijpers, Robert, ten Tusscher, Marcel, Neyns, Bart
Publicado 2021

Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors

por Rogiers, Anne, Boekhout, Annelies, Schwarze, Julia K., Awada, Gil, Blank, Christian U., Neyns, Bart
Publicado 2019

Durable Complete Response of a Recurrent Mesencephalic Glioblastoma Treated with Trametinib and Low-Dose Dabrafenib in a Patient with Neurofibromatosis Type 1

por Awada, Gil, Serruys, Daphne, Schwarze, Julia Katharina, Van De Voorde, Lien, Duerinck, Johnny, Neyns, Bart
Publicado 2020

SUN-923 Combination Immune Checkpoint Inhibitor Therapy for ACTH-Secreting Pituitary Carcinoma

por de Filette, Jeroen M K, Sol, Bastiaan, Awada, Gil, Aspeslagh, Sandrine, Andreescu, Corina E, Neyns, Bart, Velkeniers, Brigitte
Publicado 2020

Immune checkpoint inhibitor therapy for ACTH-secreting pituitary carcinoma: a new emerging treatment?

por Sol, Bastiaan, de Filette, Jeroen M K, Awada, Gil, Raeymaeckers, Steven, Aspeslagh, Sandrine, Andreescu, C E, Neyns, Bart, Velkeniers, Brigitte
Publicado 2020

Intratumoral Combinatorial Administration of CD1c (BDCA-1)(+) Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients wi...

por Schwarze, Julia Katharina, Awada, Gil, Cras, Louise, Tijtgat, Jens, Forsyth, Ramses, Dufait, Inès, Tuyaerts, Sandra, Van Riet, Ivan, Neyns, Bart
Publicado 2020

Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse

por Jansen, Yanina J. L., Willekens, Inneke, Seremet, Teofila, Awada, Gil, Schwarze, Julia Katharina, De Mey, Johan, Brussaard, Carola, Neyns, Bart
Publicado 2021

COVID-19 and Cushing’s disease in a patient with ACTH-secreting pituitary carcinoma

por de Filette, J M K, Sol, Bastiaan, Awada, Gil, Andreescu, Corina E, Unuane, David, Aspeslagh, Sandrine, Poelaert, Jan, Bravenboer, Bert
Publicado 2022

Intratumoral administration of CD1c (BDCA-1)(+) and CD141 (BDCA-3)(+) myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory...

por Schwarze, Julia Katharina, Tijtgat, Jens, Awada, Gil, Cras, Louise, Vasaturo, Angela, Bagnall, Christopher, Forsyth, Ramses, Dufait, Inès, Tuyaerts, Sandra, Van Riet, Ivan, Neyns, Bart
Publicado 2022

Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial

por Schwarze, Julia Katharina, Garaud, Soizic, Jansen, Yanina J. L., Awada, Gil, Vandersleyen, Valérie, Tijtgat, Jens, de Wind, Alexandre, Kristanto, Paulus, Seremet, Teofila, Willard-Gallo, Karen, Neyns, Bart
Publicado 2022

Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A P...

por Fasolino, Giuseppe, Awada, Gil, Moschetta, Laura, Koulalis, Jorgos Socrates, Neyns, Bart, Verhelst, Bert, Van Elderen, Peter, Nelis, Pieter, de Lichtbuer, Paul Cardon, Cools, Wilfried, Ten Tusscher, Marcellinus
Publicado 2023

Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab

por Rogiers, Anne, Leys, Christophe, Lauwyck, Justine, Schembri, Adrian, Awada, Gil, Schwarze, Julia Katharina, De Cremer, Jennifer, Theuns, Peter, Maruff, Paul, De Ridder, Mark, Bernheim, Jan L., Neyns, Bart
Publicado 2020

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy

por Seremet, Teofila, Jansen, Yanina, Planken, Simon, Njimi, Hassan, Delaunoy, Mélanie, El Housni, Hakim, Awada, Gil, Schwarze, Julia Katharina, Keyaerts, Marleen, Everaert, Hendrik, Lienard, Danielle, Del Marmol, Véronique, Heimann, Pierre, Neyns, Bart
Publicado 2019

Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)

por Awada, Gil, Ben Salama, Laila, De Cremer, Jennifer, Schwarze, Julia Katharina, Fischbuch, Lydia, Seynaeve, Laura, Du Four, Stephanie, Vanbinst, Anne-Marie, Michotte, Alex, Everaert, Hendrik, Rogiers, Anne, Theuns, Peter, Duerinck, Johnny, Neyns, Bart
Publicado 2020

A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab

por Awada, Gil, Jansen, Yanina, Schwarze, Julia Katharina, Tijtgat, Jens, Hellinckx, Lennert, Gondry, Odrade, Vermeulen, Sim, Warren, Sarah, Schats, Kelly, van Dam, Pieter-Jan, Kockx, Mark, Keyaerts, Marleen, Everaert, Hendrik, Seremet, Teofila, Rogiers, Anne, Neyns, Bart
Publicado 2021

Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial

por Duerinck, Johnny, Schwarze, Julia Katharina, Awada, Gil, Tijtgat, Jens, Vaeyens, Freya, Bertels, Cleo, Geens, Wietse, Klein, Samuel, Seynaeve, Laura, Cras, Louise, D’Haene, Nicky, Michotte, Alex, Caljon, Ben, Salmon, Isabelle, Bruneau, Michaël, Kockx, Mark, Van Dooren, Sonia, Vanbinst, Anne-Marie, Everaert, Hendrik, Forsyth, Ramses, Neyns, Bart
Publicado 2021